229 related articles for article (PubMed ID: 32321630)
1. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: A cross-sectional study.
Suzuki S; Asakura T; Namkoong H; Okamori S; Yagi K; Kamata H; Uwamino Y; Funatsu Y; Nakano Y; Nishimura T; Ishii M; Ebihara T; Betsuyaku T; Hasegawa N
Respir Med; 2018 May; 138():1-6. PubMed ID: 29724379
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.
Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
J Infect Chemother; 2018 Aug; 24(8):654-659. PubMed ID: 29705392
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.
Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):91-98. PubMed ID: 28920166
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
[TBL] [Abstract][Full Text] [Related]
6. Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
Takasaka N; Hosaka Y; Fukuda T; Shinfuku K; Chida K; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Seki A; Seki Y; Ishikawa T; Kuwano K
Respir Med; 2022 Feb; 192():106738. PubMed ID: 35051876
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease.
Matsuda S; Asakura T; Morimoto K; Suzuki S; Fujiwara K; Furuuchi K; Osawa T; Namkoong H; Ishii M; Kurashima A; Tatsumi K; Ohta K; Hasegawa N; Sasaki Y
Respir Med; 2020 Sep; 171():106086. PubMed ID: 32917357
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.
Zoumot Z; Boutou AK; Gill SS; van Zeller M; Hansell DM; Wells AU; Wilson R; Loebinger MR
Respirology; 2014 Jul; 19(5):714-22. PubMed ID: 24690015
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis.
Kitasato Y; Tao Y; Hoshino T; Tachibana K; Inoshima N; Yoshida M; Takata S; Okabayashi K; Kawasaki M; Iwanaga T; Aizawa H
Respirology; 2009 Jul; 14(5):701-8. PubMed ID: 19659648
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.
Naito M; Kurahara Y; Yoshida S; Ikegami N; Kobayashi T; Minomo S; Tachibana K; Tsuyuguchi K; Hayashi S; Suzuki K
Respir Investig; 2018 Jul; 56(4):326-331. PubMed ID: 29764749
[TBL] [Abstract][Full Text] [Related]
12. Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.
Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
BMC Infect Dis; 2019 Mar; 19(1):263. PubMed ID: 30885152
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
[TBL] [Abstract][Full Text] [Related]
14. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease.
Kobashi Y; Fukuda M; Yoshida K; Miyashita N; Niki Y; Oka M
Respirology; 2006 Nov; 11(6):809-13. PubMed ID: 17052313
[TBL] [Abstract][Full Text] [Related]
15. Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease.
Pan SW; Shu CC; Feng JY; Chien JY; Wang JY; Chan YJ; Yu CJ; Su WJ
Clin Microbiol Infect; 2021 Mar; 27(3):467.e9-467.e14. PubMed ID: 32360207
[TBL] [Abstract][Full Text] [Related]
16. A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.
Chan JF; Lau SK; Wong SC; To KK; So SY; Leung SS; Chan SM; Pang CM; Xiao C; Hung IF; Cheng VC; Yuen KY; Woo PC
Emerg Microbes Infect; 2016 Apr; 5(4):e37. PubMed ID: 27094904
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of anti-glycopeptidolipid-core IgA test for diagnosing Mycobacterium avium complex infection in lung.
Numata T; Araya J; Yoshii Y; Shimizu K; Hara H; Nakayama K; Kuwano K
Respirology; 2015 Nov; 20(8):1277-81. PubMed ID: 26338466
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection.
Urabe N; Sakamoto S; Sano G; Ito A; Homma S
J Infect Chemother; 2018 Oct; 24(10):822-827. PubMed ID: 30054229
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
